Please assess the completion status of the following clinical trial:

Trial Title: Cleancision IntRaoperative Contamination prEvention Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 and older~* BMI 15-45, inclusive~* Colorectal surgery patient, planned resection~* Incision length meets labeling requirements~* Written informed consent using the governing IRB approved form~Exclusion Criteria:~* Patients with a pre-existing stoma~* Patients undergoing emergent colorectal surgery~* Known history of contact hypersensitivity or allergy to device materials~* Prior laparotomy or abdominal surgery within a timeframe that may present a safety risk or compromise study results~* Active infection, sepsis or systemic antibiotic therapy within timeframe that may impact safety or study results~* Active participation in any other clinical study of an experimental drug or device that may impact safety or study results~* Postsurgical life expectancy is less than the study follow up period~* Subject is pregnant or lactating~* Subject is under incarceration~* Subject considered to be inoperable following exploratory surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): All study subjects will be treated using the CleanCision device.

Based on this trial design, predict the completion outcome and termination type (if applicable).